Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1)

European Journal of Medicinal Chemistry
2013.0

Abstract

A series of MMP-1 inhibitors have been identified based upon a methyl rosmarinate scaffold using structure-based drug design methods. The best compound in the series showed an IC50 value of 0.4 μM. A docking study was conducted for compound (S)-10n in order to investigate its binding interactions with MMP-1. The structure-activity relationships (SAR) were also briefly discussed. Useful SAR was established which provides important guidelines for the design of future generations of potent inhibitors against MMP-1.

Knowledge Graph

Similar Paper

Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1)
European Journal of Medicinal Chemistry 2013.0
Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis
Bioorganic & Medicinal Chemistry Letters 2015.0
Structure–activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties
European Journal of Medicinal Chemistry 2017.0
Synthesis and structure–activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Hydroxamate inhibitors of the matrix metallo-proteinases (MMPs) containing novel P1′ heteroatom based modifications
Bioorganic & Medicinal Chemistry Letters 1995.0
Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold
Bioorganic & Medicinal Chemistry 2012.0
Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors
Bioorganic & Medicinal Chemistry 2014.0
Structure–Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase
Journal of Medicinal Chemistry 2017.0
Synthesis and evaluation of 6-methylcoumarin derivatives as potent and selective monoamine oxidase B inhibitors
MedChemComm 2014.0
Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation
European Journal of Medicinal Chemistry 2017.0